Stay updated on Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- ChecktodayChange DetectedA site-wide notice announces that NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov 403 error page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe 403 error block and its HTML boilerplate (including the 403 text and Home link) were removed from the page.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied message. This prevents viewing the study record and related information on the page.SummaryDifference18%

- Check50 days agoChange DetectedThe study page adds a new site in New Delhi (Sir Gangaram Hospital) and updates overall locations, while introducing new/modified outcomes such as T1Gd+ lesion counts, an SDMT worsening definition, and NfL biomarker measurements with extended timeframes; the Pune site (Sahyadri Hospital) has been removed.SummaryDifference0.9%

Stay in the know with updates to Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.